MetLife Investment Management’s Natus Medical Inc NTUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-18,719
| Closed | -$613K | – | 2883 |
|
|
2022
Q2 | $613K | Hold |
18,719
| – | – | ﹤0.01% | 1523 |
|
|
2022
Q1 | $492K | Buy |
18,719
+3,562
| +24% | +$86.9K | ﹤0.01% | 1780 |
|
|
2021
Q4 | $360K | Hold |
15,157
| – | – | ﹤0.01% | 1688 |
|
|
2021
Q3 | $380K | Hold |
15,157
| – | – | ﹤0.01% | 1691 |
|
|
2021
Q2 | $394K | Hold |
15,157
| – | – | ﹤0.01% | 1719 |
|
|
2021
Q1 | $388K | Hold |
15,157
| – | – | ﹤0.01% | 1668 |
|
|
2020
Q4 | $304K | Hold |
15,157
| – | – | ﹤0.01% | 1764 |
|
|
2020
Q3 | $260K | Hold |
15,157
| – | – | ﹤0.01% | 1700 |
|
|
2020
Q2 | $331K | Hold |
15,157
| – | – | ﹤0.01% | 1611 |
|
|
2020
Q1 | $351K | Hold |
15,157
| – | – | ﹤0.01% | 1406 |
|
|
2019
Q4 | $500K | Hold |
15,157
| – | – | 0.01% | 1463 |
|
|
2019
Q3 | $483K | Hold |
15,157
| – | – | 0.01% | 1437 |
|
|
2019
Q2 | $389K | Hold |
15,157
| – | – | ﹤0.01% | 1629 |
|
|
2019
Q1 | $385K | Hold |
15,157
| – | – | ﹤0.01% | 1611 |
|
|
2018
Q4 | $516K | Hold |
15,157
| – | – | 0.01% | 1353 |
|
|
2018
Q3 | $540K | Hold |
15,157
| – | – | 0.01% | 1490 |
|
|
2018
Q2 | $523K | Buy |
15,157
+1,889
| +14% | +$66.2K | 0.01% | 1387 |
|
|
2018
Q1 | $446K | Sell |
13,268
-3,204
| -19% | -$101K | 0.01% | 1435 |
|
|
2017
Q4 | $629K | Buy |
+16,472
| New | +$658K | 0.01% | 1269 |
|
Other funds holding NTUS
MetLife Investment Management's NTUS Position: Q3 2022 in Review
MetLife Investment Management sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 18,719 shares — an estimated $613K sold.
MetLife Investment Management first reported a position in NTUS in Q4 2017 and held it in 19 quarters. The position peaked at $629K in Q4 2017. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.
- MetLife Investment Management reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
- MetLife Investment Management sold 18,719 Natus Medical Inc shares in Q3 2022, an estimated $613K.
- MetLife Investment Management first reported a position in Natus Medical Inc in Q4 2017 and held it in 19 quarters.
- MetLife Investment Management's Natus Medical Inc position peaked at $629K in Q4 2017.
- 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.
Based on MetLife Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.